```html

Bacterial Cellulitis – Comprehensive Medical Guide

Overview

Cellulitis is an acute, bacterial infection of the skin and the underlying soft‑tissue layers (dermis and subcutis). It commonly presents as a painful, red, warm, and swollen area that expands rapidly. While the condition can affect anyone, it is most frequent in adults > 50 years old, people with diabetes, obesity, or chronic skin conditions, and those who have had recent skin trauma.

In the United States, cellulitis accounts for roughly 14–15 million outpatient visits each year and results in > 300,000 hospital admissions annually (CDC, 2023). Worldwide, the incidence is estimated at 0.2–0.4 % of the population per year, with higher rates in low‑resource settings where access to prompt treatment may be limited (WHO, 2022).

Symptoms

Symptoms may appear within hours of bacterial entry and can progress quickly. Common manifestations include:

• Redness (erythema): sharply demarcated, often expanding 2–3 cm per hour.
• Swelling: tissue edema that makes the affected area feel firm or “tight.”
• Heat: the lesion feels hotter than surrounding skin.
• Pain or tenderness: worsens with movement of the involved limb.
• Skin tension or “tight” sensation: due to edema.
• Fever or chills: systemic signs in up to 30 % of cases.
• Regional lymphadenopathy: enlarged, tender lymph nodes near the infection.
• Blistering or bullae: may develop in severe infections or with necrotizing infections.
• Shortness of breath, rapid heart rate, or low blood pressure: suggest sepsis—a medical emergency.

In atypical cases, cellulitis can present on the face, neck, or genital region, and may be confused with allergic reactions, deep‑vein thrombosis, or gout.

Causes and Risk Factors

Primary bacterial agents

• Group A Streptococcus (Streptococcus pyogenes) – responsible for ~30‑40 % of cases.
• Staphylococcus aureus – especially methicillin‑resistant S. aureus (MRSA) in community‑associated infections.
• Other streptococci (Groups B, C, G) and Gram‑negative organisms are uncommon but can cause cellulitis in immunocompromised hosts.

How bacteria enter

Bacteria usually gain access through a breach in the skin’s protective barrier:

• Cut, abrasion, surgical incision, or puncture wound.
• Skin conditions that cause fissuring – e.g., eczema, athlete’s foot, psoriasis.
• Insect bites or animal scratches.
• Venous stasis ulcers, diabetic foot ulcers, or pressure sores.

Risk factors

• Diabetes mellitus (particularly with peripheral neuropathy).
• Chronic edema or lymphedema.
• Obesity (BMI ≥ 30 kg/m²).
• Peripheral vascular disease.
• Immunosuppression – HIV, chemotherapy, corticosteroids.
• Recent skin trauma or surgery.
• History of prior cellulitis (recurrence risk > 30 % within 5 years).
• Living in crowded or unsanitary conditions which increase skin colonization with Staph/MRSA.

Diagnosis

Cellulitis is primarily a clinical diagnosis, but certain tests help confirm the cause, assess severity, and rule out mimicking conditions.

Clinical assessment

• Detailed history – onset, trauma, comorbidities, prior infections.
• Physical exam – look for the classic “red‑warm‑painful” signs, assess size, margins, and lymph node involvement.
• Vital signs – fever, tachycardia, hypotension indicating systemic involvement.

Laboratory tests

• Complete blood count (CBC): often shows leukocytosis with left shift.
• C‑reactive protein (CRP) & ESR: elevated, useful for monitoring response.
• Blood cultures: recommended if the patient is febrile, appears septic, or has risk factors for bacteremia (e.g., immunosuppression).
• Wound swab or tissue culture: rarely yields the causative organism because cellulitis is a deep infection; however, it is useful if there is an associated abscess or ulcer.

Imaging

• Ultrasound: bedside Doppler can differentiate cellulitis from an abscess (fluid collection) and assess venous thrombosis.
• CT or MRI: indicated when necrotizing fasciitis, osteomyelitis, or deep‑space infection is suspected.

Diagnostic criteria (CDC 2022)

A diagnosis is confirmed when all of the following are present:

1. Acute skin inflammation with erythema ≥ 3 cm in diameter.
2. Presence of at least two of the following: warmth, tenderness, edema, or impaired function.
3. Absence of an alternative diagnosis (e.g., venous stasis, gout).

Treatment Options

Antibiotic therapy – the cornerstone

Empiric therapy should target the most likely organisms while awaiting culture results.

Scenario	First‑line oral agents	IV options (severe)
Uncomplicated cellulitis without MRSA risk	Penicillin V 500 mg q6h OR Cephalexin 500 mg q6h	IV Cefazolin 1‑2 g q8h
Community‑associated MRSA risk (e.g., recent skin infection, IV drug use)	Clindamycin 300‑450 mg q6h OR Doxycycline 100 mg q12h	IV Vancomycin (15–20 mg/kg q12h) OR Linezolid 600 mg q12h
Penicillin allergy (non‑anaphylactic)	Clindamycin or Doxycycline as above	IV Clindamycin 600‑900 mg q8h

Typical duration is 5‑7 days for mild disease, extending to 10‑14 days for severe infections or when an abscess is also treated.

Adjunctive therapies

• Analgesia: acetaminophen or ibuprofen for pain and fever.
• Elevation: keeps hydrostatic pressure low, reduces edema.
• Compression therapy: in chronic edema/lymphedema after the acute phase.
• Drainage of abscess: surgical incision & drainage (I&D) when a localized collection is present.

Hospitalization criteria

Patients should be admitted when any of the following are present:

• Severe systemic toxicity (fever > 39 °C, hypotension, tachycardia).
• Rapid progression of skin involvement (> 5 cm per hour) or large area (> 10 % body surface).
• Signs of necrotizing fasciitis (pain out of proportion, gas on imaging).
• Immunocompromised state or uncontrolled diabetes.
• Inability to tolerate oral medication or poor adherence.

Living with Bacterial Cellulitis

Daily management tips

• Finish the full antibiotic course, even if symptoms improve early.
• Keep the affected limb elevated above heart level for at least 15 minutes, three times daily.
• Apply gentle compression (e.g., elastic bandage) once swelling subsides, unless arterial disease is present.
• Inspect skin daily for new breaks, drainage, or worsening redness.
• Maintain good glycemic control if diabetic – target HbA1c < 7 % (per ADA).
• Hydrate well; adequate fluid intake supports immune function.
• Use non‑adhesive dressings to protect fragile skin; change as recommended.

When to follow‑up

Schedule a follow‑up visit within 48–72 hours after starting antibiotics, or sooner if symptoms worsen. Chronic cellulitis sufferers often benefit from a referral to a dermatologist or wound‑care clinic for preventive skin‑care plans.

Prevention

• Skin integrity: keep nails trimmed, treat fungal infections promptly, and use moisturizers to avoid cracking.
• Wound care: clean all cuts or abrasions with mild soap, apply an antiseptic, and cover with a sterile bandage.
• Manage chronic edema: compression stockings, physiotherapy, and manual lymphatic drainage.
• Diabetes control: regular monitoring, foot exams, and prompt treatment of plantar ulcers.
• Vaccinations: influenza and pneumococcal vaccines reduce secondary bacterial infections.
• Hand hygiene: especially for caregivers and healthcare workers to prevent transmission of MRSA.
• Antibiotic stewardship: avoid unnecessary antibiotics to reduce resistant organism colonization.

Complications

If left untreated or inadequately treated, cellulitis can lead to serious complications:

• Abscess formation: requires surgical drainage.
• Necrotizing fasciitis: rapidly progressive tissue death; surgical emergency.
• Sepsis and septic shock: systemic inflammatory response with high mortality (≈ 25 % in severe cases).
• Chronic lymphedema: due to lymphatic damage, increasing future infection risk.
• Deep‑vein thrombosis (DVT): inflammation can precipitate clot formation in the affected limb.
• Scarring or skin contractures: may limit joint range of motion.

Recurrence is common; about 10‑30 % of patients experience another episode within a year (Cleveland Clinic, 2023).

When to Seek Emergency Care

```